癌症多学科团队工作：证据是什么？
被引量：2
Muhidisciplinary team working in cancer： what is the evidence？
摘要
癌症治疗越来越多地由多学科团队完成。Cath Taylor及其同事认为，需要更有力的证据证实其有效性。
出处
《英国医学杂志中文版》
2010年第4期211-214,共4页
The BMJ Chinese Edition
参考文献31
-
1Department of Health. National service framework for diabetes: standards. London: DH, 2001.
-
2Department of Health. National service framework for older people. London : DH, 2001.
-
3National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care. NICE, 2004.
-
4Department of Health. Coronary heart disease: national service framework for coronary heart disease-modern standards and service models. London: DH, 2000.
-
5Department of Health. Policy framework for commissioning cancer services: a report by the expert advisory group on cancer to the chief medical officers of England and Wales. London: DH, 1995.
-
6Richards MA, Bantu M, Dowsett M. Provision of breast services in the UK: the advantages of specialist breast units. British Breast Group, 1994.
-
7Cancer Guidance Sub-Group of the Clinical Outcomes Group. Improving outcomes in breast cancer. London: DH, 1996.
-
8National Institute for Health and Clinical Excellence. Guidance on cancer services: improving outcomes for people with brain and other CNS tumours. NICE, 2006.
-
9Department of Health. The manual for cancer services. London: DH, 2004.
-
10National Cancer Action Team. National cancer peer review programme 2004- 2007. National report: an overview of the findings from the second national round of peer reviews of cancer services in England. NCAT, 2008.
同被引文献11
-
1结直肠癌诊疗规范（2010年版）[J].中华外科杂志,2011,49(2):97-104. 被引量：63
-
2无,陈孝平.胆管癌诊断与治疗——外科专家共识[J].临床肝胆病杂志,2015,31(1):12-16. 被引量：82
-
3王坤远,杨紫荆,于文轩,刘莉,陈征,郭亚兵.肝癌多学科协作组诊疗的预后影响因素分析[J].中华肝脏病杂志,2018,26(11):829-834. 被引量：14
-
4肖海,朱思泉,马星,曹德品.“5+3”一体化临床医学人才培养模式的构建与思考[J].医学教育管理,2016,2(4):567-571. 被引量：39
-
5Jian-Zhen Lin,Yi Bai,An-Qiang Wang,Jun-Yu Long,Wei-Yu Xu,Ke Hu,Lin Zhao,Jie Pan,Xin-Ting Sang,Hai-Tao Zhao.Multidisciplinary management of hepatobiliary tumors in the era of precision medicine[J].Hepatobiliary & Pancreatic Diseases International,2018,17(5):381-382. 被引量：1
-
6无,梁后杰,秦叔逵,沈锋,毕锋,钦伦秀,戴广海,李恩孝,刘秀峰,顾艳宏,殷保兵,方维佳,郑怡,马虹,邱文生,郭婧,陆明,彭永海,周军,谢赣丰.CSCO胆道系统肿瘤诊断治疗专家共识(2019年版)[J].临床肿瘤学杂志,2019,24(9):828-838. 被引量：106
-
7科技部传染病防治重大专项课题“病毒性肝炎相关肝癌外科综合治疗的个体化和新策略研究”专家组,陈孝平,沈锋,王葵,夏勇,程张军.肝内胆管癌外科治疗中国专家共识(2020版)[J].中华消化外科杂志,2021,20(1):1-15. 被引量：73
-
8王冲,程石.肝内胆管癌——国内外专家共识及指南解读[J].外科理论与实践,2021,26(2):124-129. 被引量：9
-
9张斌豪,李开艳,邱红,李震,朱小华,况东,吴亮,陈倩,胡学梅,程恒辉,倪明,邹思娟,胡萍,李勇,丁则阳,陈琳,覃华,刘梅,张万广,陈孝平,张必翔.肝胆胰疾病MDT单中心开展七年经验[J].腹部外科,2021,34(4):285-290. 被引量：7
-
10Binhao Zhang,Jian Zhou,Weifen Xie,Kaishan Tao,Shichun Lu,Xianglin Yuan,Lianxin Liu,Weilin Wang,Yilei Mao,Ping Bie,Jingfeng Liu,Xinyu Bi,Zhiwei Zhang,Changhong Liang,Jianqiang Cai,Zhixiang Jian,Yi Lv,Peng Zhu,Wei Zhang,Hongqiang Yang,Weiping Zhou,Bixiang Zhang,Xiaoping Chen.Expert consensus on organizing the multidisciplinary team(MDT) diagnosis and treatment of hepato-pancreato-biliary diseases in China[J].Science China(Life Sciences),2022,65(5):1036-1039. 被引量：1
引证文献2
-
1袁宵寅,王超,何正为,姜雪薇,吴成宪,兰润虎,郭玲,丹增阿旺,次仁平措,杨振华,张斌豪.多学科团队诊疗模式在肝胆胰疾病领域的发展与现状[J].中华肝胆外科杂志,2024,30(3):224-228.
-
2陶润仪,高山,刘博豪,陈喆,黄嘉琪,李益行,王芝馀,张广健.多学科协作与案例导向学习组合教学方法与传统教学模式下的住院医师规范化培训学员影像诊断能力比较[J].临床医学研究与实践,2024,9(20):177-180.
-
1杨红忠,张卫东,杨华平,胡成平.非小细胞肺癌组织Cath B表达及意义[J].中南大学学报（医学版）,2005,30(6):729-730. 被引量：1
-
2白秀萍,李伟,朱利利.宫颈腺癌组织中组织蛋白酶D的表达及其临床意义[J].解放军医药杂志,2014,26(7):68-70. 被引量：3
-
3张伟,王蓁,林伟,王翔宇,江金潇.子宫内膜癌组织中uPA及Cath-D的表达及意义(英文)[J].现代生物医学进展,2014,14(20):3891-3895.
-
4杨红忠,张卫东,杨华平,苏晓丽,胡成平.非小细胞肺癌组织蛋白酶D表达及意义[J].实用预防医学,2004,11(4):719-720.
-
5李强,黄波,李奕.组织蛋白酶D在非小细胞肺癌中的表达及临床意义[J].实用肿瘤学杂志,2006,20(3):208-209. 被引量：5
-
6朱坤,徐楠楠,马波.肺腺癌中组织蛋白酶-D和基质金属蛋白酶-7的关系[J].中国老年学杂志,2016,36(24):6149-6151.
-
7答邦明,王晓娟,丁亚文,冯刚,费雁,桂华伟.结肠腺癌中组织蛋白酶D和基质金属蛋白酶-7的表达及意义[J].中国老年学杂志,2017,37(4):914-916.
-
8展翼翼,达春丽,刘春玲.肺腺癌中CD44v6和组织蛋白酶D的表达及临床意义[J].中国老年学杂志,2017,37(1):119-121. 被引量：1
-
9Ayhan A,周希亚（摘） 向阳（校）.交界性卵巢肿瘤的复发和预后因素[J].国外医学（计划生育．生殖健康分册）,2006,25(5):292-293.
-
10梁健,黄开红,李海刚.大肠癌桩蛋白和组织蛋白酶D的表达及意义[J].中国肿瘤临床,2003,30(9):660-661. 被引量：11
